TY - JOUR
T1 - The shifting trends towards a robotically-assisted surgical interface
T2 - Clinical and financial implications
AU - Abitbol, Jeremie
AU - Munir, Aqsa
AU - How, Jeffrey
AU - Lau, Susie
AU - Salvador, Shannon
AU - Kogan, Liron
AU - Kessous, Roy
AU - Breitner, Leslie
AU - Frank, Russell
AU - Kucukyazici, Beste
AU - Gotlieb, Walter H.
N1 - Publisher Copyright:
© 2020
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Objectives: Some hospitals have invested in robotic surgery platforms to stimulate the uptake of minimally invasive surgery (MIS) and offer its benefits to more patients. The objectives were to determine the clinical and financial effects, as well as the policy implications, of a robotics program in an academic gynecologic oncology division over time. Methods: Patients treated for endometrial, cervical, and ovarian cancer within a gyn-oncology division between 2003 and 2016 were included in the current study. Clinical outcomes were described in function of surgical approach (laparotomy, laparoscopy, and robotic surgery) and tumor site. The net present value and the return on investment of the robotics program were approximated using previously reported treatment costs from our center. Results: The use of MIS soared from a high of 15% to 91% before and after the introduction of robotics in December 2007, respectively. Across all tumor sites, MIS procedures were associated with diminished blood loss and a shorter hospital stay (p < 0.0001). The use of robotics in gyn-oncology resulted in cost savings. Conclusions: Robotic surgery was instrumental in catalyzing the shift from open surgery to MIS and amplifying the number of patients who benefited from less invasive surgery. Continued investments in robotics and the digitization of surgery could help further drive innovation and expand its applications.
AB - Objectives: Some hospitals have invested in robotic surgery platforms to stimulate the uptake of minimally invasive surgery (MIS) and offer its benefits to more patients. The objectives were to determine the clinical and financial effects, as well as the policy implications, of a robotics program in an academic gynecologic oncology division over time. Methods: Patients treated for endometrial, cervical, and ovarian cancer within a gyn-oncology division between 2003 and 2016 were included in the current study. Clinical outcomes were described in function of surgical approach (laparotomy, laparoscopy, and robotic surgery) and tumor site. The net present value and the return on investment of the robotics program were approximated using previously reported treatment costs from our center. Results: The use of MIS soared from a high of 15% to 91% before and after the introduction of robotics in December 2007, respectively. Across all tumor sites, MIS procedures were associated with diminished blood loss and a shorter hospital stay (p < 0.0001). The use of robotics in gyn-oncology resulted in cost savings. Conclusions: Robotic surgery was instrumental in catalyzing the shift from open surgery to MIS and amplifying the number of patients who benefited from less invasive surgery. Continued investments in robotics and the digitization of surgery could help further drive innovation and expand its applications.
KW - Capital budgeting
KW - Gynecologic oncology
KW - Health services research
KW - Healthcare management
KW - Project valuation
KW - Robotic surgery
KW - Surgical oncology
UR - http://www.scopus.com/inward/record.url?scp=85082869527&partnerID=8YFLogxK
U2 - 10.1016/j.hlpt.2020.03.003
DO - 10.1016/j.hlpt.2020.03.003
M3 - Article
AN - SCOPUS:85082869527
SN - 2211-8837
VL - 9
SP - 157
EP - 165
JO - Health Policy and Technology
JF - Health Policy and Technology
IS - 2
ER -
